SCHEMBL7090508

SCHEMBL7090508

O=C(Cl)C(=O)ON1C(=O)C=C(c2c[nH]c3ccc(Br)cc23)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.40
EGFR P00533 1/20 0.39
ERBB2 P04626 1/20 0.39
IGF1R P08069 1/20 0.39
PDGFRB P09619 1/20 0.39
KIT P10721 1/20 0.39
PDGFRA P16234 1/20 0.39
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39
KDR P35968 1/20 0.39
TEK Q02763 1/20 0.39
CAMK2D Q13557 2/20 0.39
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRB2 P47870 1/20 0.38
HTR1A P08908 2/20 0.37
HTR7 P34969 2/20 0.37
HTR6 P50406 2/20 0.37
DRD2 P14416 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2937196 0.76 CAMK2D (0.49) NR4A2EGFRERBB2IGF1RPDGFRB
SCHEMBL5429556 0.67 GPR84 (0.62) NR4A2EGFRHTR1AHTR7HTR6
SCHEMBL7737770 0.67 PDGFRB (0.44) NR4A2EGFRERBB2IGF1RPDGFRB
SCHEMBL5879252 0.67 PDGFRB (0.50) NR4A2EGFRERBB2IGF1RPDGFRB
SCHEMBL7826604 0.65 KDR (0.68) EGFRERBB2IGF1RPDGFRBKIT
SCHEMBL20624158 0.65 SIRT2 (0.63) NR4A2EGFRERBB2IGF1RPDGFRB
SCHEMBL14215759 0.64 HTR1A (0.55) NR4A2EGFRCAMK2DHTR1AHTR7
SCHEMBL1558405 0.64 NR4A2 (0.61) NR4A2GABRA1GABRB1GABRA3GABRB2
SCHEMBL27795085 0.64 GABRA1 (0.64) NR4A2GABRA1GABRB1GABRA3GABRB2
SCHEMBL28514484 0.64 PTPN1 (0.55) EGFRERBB2IGF1RPDGFRBKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1283836-A2 NEUROPROTECTIVE AND ANTI-PROLIFERATIVE COMPOUNDS Aegera Therapeutics Inc. (CA) 2003-02-19 EP disclosed
WO-2001087887-A2 NEUROPROTECTIVE AND ANTI-PROLIFERATIVE COMPOUNDS AEGERA THERAPEUTICS INC. (CA) 2001-11-22 WO disclosed